Literature DB >> 17853253

Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification.

Klaus Mann1, Jeffrey M Rothschild, Carol A Keohane, James A Chu, David W Bates.   

Abstract

Abstract Adverse drug events and medication errors have received extensive study recently in a variety of clinical populations, though compared to many other areas relatively little work has focused on this area in psychiatry, especially with respect to the contribution of error to harm. The goal of this paper is to discuss methodological issues around measurement of medication safety in psychiatric patients. Against the background of a systems approach, a modern perspective of error management is discussed, and a multidimensional procedure for detection and classification of incidents related to the medication process is presented. This method has proven successful in non-psychiatric settings yielding the current best estimate of error rates and providing insight into the underlying causes. While this general approach can be adapted to the psychiatric setting, a number of issues make measurement especially challenging in psychiatry. These include the fluctuating course of psychiatric disorders, reduced patient adherence to the medication process, adverse effects which are often similar to symptoms of the underlying disorder, the frequent use of wide dose intervals depending on the clinical situation, and the presence of many drug-drug interactions. Data collected by means of the presented approach provide a basis for the development of effective strategies to reduce the risk of medication errors and thus improve patient safety in psychiatric care.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17853253     DOI: 10.1080/15622970601178056

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  13 in total

1.  An expert panel assessment of comprehensive medication reviews for clients of community mental health teams.

Authors:  Natasa Gisev; J Simon Bell; Claire L O'Reilly; Alan Rosen; Timothy F Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-10-15       Impact factor: 4.328

2.  Evaluating the safety of mental health-related prescribing in UK primary care: a cross-sectional study using the Clinical Practice Research Datalink (CPRD).

Authors:  Wael Y Khawagi; Douglas Steinke; Matthew J Carr; Alison K Wright; Darren M Ashcroft; Anthony Avery; Richard Neil Keers
Journal:  BMJ Qual Saf       Date:  2021-08-25       Impact factor: 7.418

3.  Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.

Authors:  Balthasar L Hug; Daniel J Witkowski; Colin M Sox; Carol A Keohane; Diane L Seger; Catherine Yoon; Michael E Matheny; David W Bates
Journal:  J Gen Intern Med       Date:  2009-11-06       Impact factor: 5.128

4.  Prevalence, nature and predictors of prescribing errors in mental health hospitals: a prospective multicentre study.

Authors:  Richard N Keers; Steven D Williams; Joe J Vattakatuchery; Petra Brown; Joan Miller; Lorraine Prescott; Darren M Ashcroft
Journal:  BMJ Open       Date:  2014-10-01       Impact factor: 2.692

5.  Monitoring of patients treated with lithium for bipolar disorder: an international survey.

Authors:  M Nederlof; E R Heerdink; A C G Egberts; I Wilting; L J Stoker; R Hoekstra; R W Kupka
Journal:  Int J Bipolar Disord       Date:  2018-04-14

6.  Identifying potential prescribing safety indicators related to mental health disorders and medications: A systematic review.

Authors:  Wael Y Khawagi; Douglas T Steinke; Joanne Nguyen; Richard N Keers
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

7.  Drug-drug interactions and pharmacists' interventions among psychiatric patients in outpatient clinics of a teaching hospital in Saudi Arabia.

Authors:  Yazed AlRuthia; Hadeel Alkofide; Fahad Dakheel Alosaimi; Ibrahim Sales; Albandari Alnasser; Aliah Aldahash; Lama Almutairi; Mohammed M AlHusayni; Miteb A Alanazi
Journal:  Saudi Pharm J       Date:  2019-05-13       Impact factor: 4.330

8.  Prevalence, Nature, Severity and Preventability of Adverse Drug Events in Mental Health Settings: Findings from the MedicAtion relateD harm in mEntal health hospitals (MADE) Study.

Authors:  Ghadah H Alshehri; Darren M Ashcroft; Joanne Nguyen; Mark Hann; Richard Jones; Kristof Seaton; Graham Newton; Richard N Keers
Journal:  Drug Saf       Date:  2021-07-05       Impact factor: 5.606

9.  Pharmacist-Led Medication Reviews to Identify and Collaboratively Resolve Drug-Related Problems in Psychiatry - A Controlled, Clinical Trial.

Authors:  Carolin Wolf; Anne Pauly; Andreas Mayr; Teja Grömer; Bernd Lenz; Johannes Kornhuber; Kristina Friedland
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

10.  The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.

Authors:  Nobutaka Ayani; Mio Sakuma; Takeshi Morimoto; Toshiaki Kikuchi; Koichiro Watanabe; Jin Narumoto; Kenji Fukui
Journal:  BMC Psychiatry       Date:  2016-08-30       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.